One of Heather Bell's standout messages from #ECO2025 is the importance of women's health in the field of obesity management. Watch the video to find out more!

It's #InsulinSafetyWeek. A week all about raising awareness of insulin safety. Why not take our module to make sure you're up to date on the latest information: eu1.hubs.ly/H0k55NY0 #InsulinSafetyWeek #InsulinSafetyWeek2025 #ThinkInsulin

Updated guidance from British Menopause Society clarifying issues to consider when incretin-based therapies, particularly semaglutide and tirzepatide, are prescribed in women using HRT. Access guidance here: eu1.hubs.ly/H0kfPRn0

A completely packed room to open this year's 16th Welsh PCDO Society Conference. Julia Platts is exploring Diabetes service provision and management strategies in 2025. #WelshPCDO #Diabetes2025

Fancy trying some consultations with 3 #TD2M patients who may be ready for #CGM? See what you would do for each case compared to our experts, sign up now for FREE , 2 cases already available issuesandanswers.org/resources/cont… Jane Diggle Nicola Milne RN QN Su Down Dexcom

As ever? A huge privilege to speak to primary care colleagues speaking about the issues around #T2D in the Young (or as I say- listen to Shivani Misra ) Lest we ever forget? A lot of the credit for the #Diabetes outcomes of the #NHS? Down to primary care led by GP

Curious about what makes the Welsh PCDO conference a must-attend event? 🌟 Our first-timers have shared their experiences & their insights might just convince you to join us next year! From inspiring sessions to invaluable networking opportunities, there's something for everyone

Another fantastic event in Crawley! Next up, we're heading to Bristol on 17th June. Don't miss out on earning 3 CPD points while enhancing your skills in type 2 diabetes care. eu1.hubs.ly/H0kZlxd0 Sponsored by an educational grant from Abbott’s Diabetes Care Division.

2 weeks to go until our London Conference at the RCGP, Euston! Join our expert panel to learn how to provide the best care for people with diabetes and a host of other long-term conditions. Register now for Wednesday 2nd July: eu1.hubs.ly/H0l3-8m0

Indications, effects and prescribing tips for the non-steroidal selective MRA, finerenone. Read our quick guide here: eu1.hubs.ly/H0l5vlH0

Thrilled to finally share what has kept me occupied these past few months; our The Lancet Series on early-onset type 2 diabetes is out! Has been an honour to be the Lead Author for this Series brining together global experts; thanks Callam Davidson for inviting me People

So delighted that this is now published. Wonderful working with Teffy Thomas and a huge ‘Thank You’ to all our brilliant contributors and reviewers 📕 💻 ✍️ 📕 academic.oup.com/book/60566?sea…

Naresh Kanumilli and Nicola Milne opening today's London conference of the PCDO Society at the RCGP.

Naresh Kanumilli welcomes us to our London conference. Free education on diabetes and a host of long-term conditions. On-demand resources coming soon! eu1.hubs.ly/H0lrZt90

Once more, obesity drugs played a large role in the headline studies at ADA 2025. Amid this backdrop, the launch of the first ADA standards of obesity care was welcome. In this short report, Pam Brown reviews the highlights of the conference: eu1.hubs.ly/H0lKyvs0

Our latest At a glance factsheet outlines the links between diabetes and dementia, and the risks associated with cognitive decline in people with diabetes: eu1.hubs.ly/H0m0_Tb0

We are delighted to launch our 2024-25 impact report; the result of 40-plus clinicians from across Greater Manchester working together to improve health and care services england.nhs.uk/north-west/wp-…

Elections to the PCDO Society committee are in November. Help steer the Society! This year, we are particularly seeking applications from the NURSING PROFESSION. eu1.hubs.ly/H0mhF3J0

Levemir insulin is to be discontinued, with an anticipated supply end date of December 2026. In response to this, ABCD and PCDO Society have published joint guidance to support clinicians in selecting and prescribing alternative insulins. 👉 eu1.hubs.ly/H0mmwQ80

Naresh Kanumilli meets Philip Newland-Jones, Consultant Pharmacist in Diabetes and Endocrinology, to discuss the discontinuation of Levemir (insulin detemir), and the joint guidance from the PCDO Society and ABCD Diabetes 👉 eu1.hubs.ly/H0mn2lB0